4//SEC Filing
CHASE WILLIAM J 4
Accession 0001179110-19-002371
CIK 0001551152other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 5:20 PM ET
Size
14.3 KB
Accession
0001179110-19-002371
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
CHASE WILLIAM J
EVP, Chief Financial Officer
Transactions
- Award
Common Stock, $0.01 par value
2019-02-21+22,150→ 127,013 total - Award
Option (right to buy)
2019-02-21+60,747→ 60,747 totalExercise: $79.02From: 2020-02-21Exp: 2029-02-20→ Common Stock (60,747 underlying) - Award
Common Stock, $0.01 par value
2019-02-21+14,989→ 157,947 total - Award
Common Stock, $0.01 par value
2019-02-21+15,945→ 142,958 total - Award
Common Stock, $0.01 par value
2019-02-21+8,481→ 166,428 total
Holdings
- 501(indirect: By Spouse)
Common stock, $0.01 par value
Footnotes (6)
- [F1]Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019.
- [F2]Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on adjusted earnings per share and relative total shareholder return measures. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019.
- [F3]Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019.
- [F4]Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019.
- [F5]The reporting person disclaims beneficial ownership of these securities.
- [F6]Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 20,249 on February 21, 2020, 20,249 on February 21, 2021, and 20,249 on February 21, 2022.
Documents
Issuer
AbbVie Inc.
CIK 0001551152
Entity typeother
Related Parties
1- filerCIK 0001563572
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 5:20 PM ET
- Size
- 14.3 KB